P3781
Use of Florbetapir-PET for Imaging β-Amyloid PathologyCorrelation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomographyUsing PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies.From Alois to Amyvid: seeing Alzheimer disease.Amyloid imaging with AV45 ((18)F-florbetapir) in a cognitively normal AβPP duplication carrierPerformance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects
P921
Q22253015-9E98B0F6-C644-4228-A621-DA0873BEC687Q35776066-B22250B0-0239-4018-B9F7-C828B2344EE2Q35777166-0CFD7207-1090-49DF-A2F6-912F1C1DF548Q35861376-D781664F-FD5A-4CF2-883F-119598D23330Q36310176-3D174696-4974-46BF-8F3D-31D8AFE5EF18Q42967351-5C4BADEB-EFBC-4E63-A404-D4DDC8DBBB08Q44540771-3E9896F3-834A-4668-99E4-743B15F04C37Q48455136-22F57E10-CEE3-43A3-A539-28A354771B5FQ48493687-92BC3AA7-709F-478E-99D3-E996FBFE0645Q50758279-91117AF6-D8C0-4303-B29E-9E859542426AQ50972863-575C2D21-6BB0-4396-A906-FC1E2811B452Q53330513-C88E6933-6B3B-411C-87D3-72D8346BAE67Q82883251-D8B809B2-270E-463D-A769-F1480D3FB39EQ83437623-00AC5CE6-6889-41FD-8D94-3ECF85F3979C
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Florbetapir (18F)
@en
Florbetapir (18F)
@nl
Florbetapir (18F)
@vi
Florbetapir
@sh
Florbetapir
@sr
Φλορβεταπίρη (18F)
@el
فلوربيتابير (18F)
@ar
type
label
Florbetapir (18F)
@en
Florbetapir (18F)
@nl
Florbetapir (18F)
@vi
Florbetapir
@sh
Florbetapir
@sr
Φλορβεταπίρη (18F)
@el
فلوربيتابير (18F)
@ar
altLabel
(18f)av-45
@en
18F-AV-45
@en
18F-florbetapir
@en
18f-av45
@en
4-((1e)-2-(6-(2-(2-(2-(18f)flu ...... )ethenyl)-n- methylbenzenamine
@en
4-{(E)-2-[6-(2-{2-[2-(18F)fluo ...... -3-yl]ethenyl}-N-methylaniline
@en
Florbetapir F-18
@en
Florbetapir F18
@en
[18F]Florbetapir
@en
av-45 f-18
@en
prefLabel
Florbetapir (18F)
@en
Florbetapir (18F)
@nl
Florbetapir (18F)
@vi
Florbetapir
@sh
Florbetapir
@sr
Φλορβεταπίρη (18F)
@el
فلوربيتابير (18F)
@ar
P486
P592
P6366
P661
P662
P665
P683
P2017
CNC1=CC=C(C=C1)/C=C/C2=CN=C(C=C2)OCCOCCOCC[18F]
P2067
359.187456
P2115
N0000192019
P231
956103-76-7
P233
CNC1=CC=C(C=C1)C=CC2=CN=C(C=C2)OCCOCCOCCF
P234
1S/C20H25FN2O3/c1-22-19-7-4-17 ...... 16,22H,10-15H2,1H3/b3-2+/i21-1
P235
YNDIAUKFXKEXSV-CRYLGTRXSA-N
P267
P274
C₂₀H₂₅FN₂O₃
P3117
DTXSID80241898